I thank the Minister for letting me ask her a question. First, how will that operate if we continue to apply the directive and the other member states apply the updated regulation? There is a rather peculiar situation in justice and home affairs where that is envisaged, although I have never been sure how it is supposed to operate. Perhaps she can tell us how it will operate for clinical trials and how we will avoid a bumpy playing field. Secondly, can she explain what the noble and learned Lord, Lord Keen of Elie, meant? What category of regulations was he talking about if he was not talking about the clinical trials regulation?
European Union (Withdrawal) Bill
Proceeding contribution from
Baroness Ludford
(Liberal Democrat)
in the House of Lords on Monday, 12 March 2018.
It occurred during Committee of the Whole House (HL)
and
Debate on bills on European Union (Withdrawal) Bill.
About this proceeding contribution
Reference
789 c1338 Session
2017-19Chamber / Committee
House of Lords chamberLibrarians' tools
Timestamp
2018-03-13 12:43:49 +0000
URI
http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000127
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000127
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Lords/2018-03-12/18031212000127